MIP-1β neutralization modifies gut microbiota profile and improves systemic metabolism

A new research article entitled "Direct CCL4 inhibition Modulates Gut Microbiota, Reduces Circulating Trimethylamine N-Oxide, and Improves Glucose and Lipid Metabolism in High-Fat-Diet-Induced Diabetes Mellitus" by Ting-Ting Chang and Jaw-Wen Chen, has been recently published at Dove Medical Press Journal of Inflammation Research.

J Inflamm Res. 2021;14:6237-6250

https://doi.org/10.2147/JIR.S343491

December 2021

.